{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:33:34Z","timestamp":1761734014629,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007472","name":"UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004477","name":"US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Healthcare Quality Improvement Partnership"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmg.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T23:37:43Z","timestamp":1526773063000},"page":"539-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Projected number of children with isolated spina bifida or down syndrome in England and Wales by 2020"],"prefix":"10.1016","volume":"61","author":[{"given":"Kate E.","family":"Best","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana V.","family":"Glinianaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghu","family":"Lingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2018.05.012_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/bdra.20468","article-title":"Trends in the postfortification prevalence of spina bifida and anencephaly in the United States","volume":"82","author":"Boulet","year":"2008","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejmg.2018.05.012_bib2","series-title":"Official Statistics","article-title":"English Indices of deprivation 2015","author":"Dept of Communities and Local Government","year":"2015"},{"issue":"2","key":"10.1016\/j.ejmg.2018.05.012_bib3","article-title":"Folic acid and human reproduction\u2014ten important issues for clinicians","volume":"8","author":"Dunlap","year":"2011","journal-title":"J. Exp. Clin. Assist. Reprod."},{"year":"2016","series-title":"EUROCAT Prevalence Tables 2000-2014","author":"EUROCAT","key":"10.1016\/j.ejmg.2018.05.012_bib4"},{"year":"2008","series-title":"EUROCAT Syndrome Guide: Definition and Coding of Syndromes","author":"European Surveillance of Congenital Anomalies","key":"10.1016\/j.ejmg.2018.05.012_bib5"},{"year":"2014","series-title":"Chapter 3.3: EUROCAT Subgroups of Congenital Anomalies (Version 2014)","author":"European Surveillance of Congenital Anomalies","key":"10.1016\/j.ejmg.2018.05.012_bib6"},{"key":"10.1016\/j.ejmg.2018.05.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.06.007","article-title":"Direct health care costs of children and adolescents with Down syndrome","volume":"159","author":"Geelhoed","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2018.05.012_bib8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ejhg.2008.122","article-title":"Twenty-year trends in prevalence and survival of Down syndrome","volume":"16","author":"Irving","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2018.05.012_bib9","article-title":"Long term trends in prevalence of neural tube defects in Europe: population based study","volume":"351","author":"Khoshnood","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ejmg.2018.05.012_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2012.94","article-title":"Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2018.05.012_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b3794","article-title":"Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the national Down syndrome cytogenetic register","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"year":"2014","series-title":"The National Down Syndrome Cytogenic Register for England and Wales: 2013 Annual Report","author":"Morris","key":"10.1016\/j.ejmg.2018.05.012_bib12"},{"key":"10.1016\/j.ejmg.2018.05.012_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jms.9.1.2","article-title":"Revised estimates of the maternal age specific live birth prevalence of Down's syndrome","volume":"9","author":"Morris","year":"2002","journal-title":"J. Med. Screen"},{"key":"10.1016\/j.ejmg.2018.05.012_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1469-8749.2009.03543.x","article-title":"Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study","volume":"52","author":"Oakeshott","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"year":"2014","series-title":"Subnational Population Projections, Births by Age of Mother: SNPP Z3","author":"Office for National Statistics (ONS)","key":"10.1016\/j.ejmg.2018.05.012_bib15"},{"year":"2014","series-title":"Population Projections for Wales","author":"Office for National Statistics (ONS)","key":"10.1016\/j.ejmg.2018.05.012_bib16"},{"year":"2014","series-title":"Cigarette Smoking by Region, by Country","author":"Office for National Statistics (ONS)","key":"10.1016\/j.ejmg.2018.05.012_bib17"},{"year":"2015","series-title":"Live Births by Area of Usual Residence","author":"Office for National Statistics (ONS)","key":"10.1016\/j.ejmg.2018.05.012_bib18"},{"year":"2016","series-title":"Population of the United Kingdom by Country of Birth and Nationality","author":"Office for National Statistics (ONS)","key":"10.1016\/j.ejmg.2018.05.012_bib19"},{"key":"10.1016\/j.ejmg.2018.05.012_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/bdra.20360","article-title":"Health care expenditures of children and adults with spina bifida in a privately insured US population","volume":"79","author":"Ouyang","year":"2007","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejmg.2018.05.012_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/bdra.23154","article-title":"Knowledge and periconceptional use of folic acid for the prevention of neural tube defects in ethnic communities in the United Kingdom: systematic review and meta-analysis","volume":"97","author":"Peake","year":"2013","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejmg.2018.05.012_bib22","series-title":"NHS England","article-title":"NHS public health functions agreement 2017-18 service specification no.16 NHS fetal anomaly screening programme -screening for Down's, edwards' and Patau's syndromes (trisomy 21, 18 & 13)","author":"Public Health England","year":"2017"},{"key":"10.1016\/j.ejmg.2018.05.012_bib23","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/bdra.23084","article-title":"Hospital use, associated costs, and payer status for infants born with spina bifida","volume":"94","author":"Radcliff","year":"2012","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejmg.2018.05.012_bib24","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.1542\/peds.2011-3051","article-title":"Predictors of survival in children born with Down syndrome: a registry-based study","volume":"129","author":"Rankin","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejmg.2018.05.012_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1503\/cmaj.1040254","article-title":"Maternal ethnicity and risk of neural tube defects: a population-based study","volume":"171","author":"Ray","year":"2004","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ejmg.2018.05.012_bib26","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejmg.2018.05.012_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pd.2403","article-title":"The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome)","volume":"30","author":"Savva","year":"2010","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ejmg.2018.05.012_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jpeds.2012.05.040","article-title":"Improved survival among children with spina bifida in the United States","volume":"161","author":"Shin","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2018.05.012_bib29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2009.113","article-title":"Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis","volume":"301","author":"Stothard","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.ejmg.2018.05.012_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(09)61922-X","article-title":"20-year survival of children born with congenital anomalies: a population-based study","volume":"375","author":"Tennant","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmg.2018.05.012_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00381-013-2194-5","article-title":"Maternal smoking during pregnancy and neural tube defects in offspring: a meta-analysis","volume":"30","author":"Wang","year":"2014","journal-title":"Child's Nerv. Syst."},{"key":"10.1016\/j.ejmg.2018.05.012_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpeds.2007.09.045","article-title":"Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study","volume":"152","author":"Weijerman","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2018.05.012_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1542\/peds.2005-0592","article-title":"Decline in the prevalence of spina bifida and anencephaly by race\/ethnicity: 1995\u20132002","volume":"116","author":"Williams","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejmg.2018.05.012_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1365-3016.2001.00371.x","article-title":"Survival of infants with spina bifida: a population study, 1979-94","volume":"15","author":"Wong","year":"2001","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.ejmg.2018.05.012_bib35","series-title":"International Statistical Classification of Diseases and Related Health Problems: 10th Revision","article-title":"Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ejmg.2018.05.012_bib36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","article-title":"The population prevalence of Down's syndrome in England and Wales in 2011","volume":"21","author":"Wu","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2018.05.012_bib37","first-page":"128","article-title":"9 Spina bifida and hydrocephalus","author":"Yeates","year":"2016","journal-title":"Textbook of Clinical Neuropsychology"},{"key":"10.1016\/j.ejmg.2018.05.012_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151586","article-title":"Describing the prevalence of neural tube defects worldwide: a systematic literature review","volume":"11","author":"Zaganjor","year":"2016","journal-title":"PLoS One"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972121830154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972121830154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:45:38Z","timestamp":1761709538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972121830154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S176972121830154X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2018.05.012","relation":{},"ISSN":["1769-7212"],"issn-type":[{"type":"print","value":"1769-7212"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Projected number of children with isolated spina bifida or down syndrome in England and Wales by 2020","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}